New Jersey · 222
A 1510
Improves access to lower cost generic and biosimilar drugs and revises certain requirements regarding dispensing of biosimilar drugs by pharmacies.*
Bill record: Open States bulk CSV (bills/votes) ocd-bill/5115512d-a30c-4094-9b47-e11334f27f72 CC0-1.0
Summary AI-generated
New Jersey Bill A 1510 aims to improve access to lower-cost generic and biosimilar drugs. The legislation also revises certain requirements regarding the dispensing of biosimilar drugs by pharmacies.
Software-generated, grounded only in the bill's own fields (it does not invent outcomes, amounts, or dates). Provenance: Open States bulk CSV (bills/votes) CC0-1.0 GovTally LLM enrichment (local oMLX)
Issue tags AI-classified
Classified by a local model from the bill's text; confidence shown. GovTally LLM enrichment (local oMLX)
Sponsors
- Roy Freiman Democratic lead
- Sterley Stanley Democratic lead
Roll-call votes on this bill
| Motion / question | Chamber | Stage | Roll | Outcome | Yea | Nay | Other | Date | Source |
|---|---|---|---|---|---|---|---|---|---|
| Assembly Financial Institutions and Insurance Committee: Reported with… | lower | — | 1705445 | pass | 12 | 0 | 2 | Jun 4, 2026 | LegiScan API legiscan-1705445 LegiScan-ToS |